Press Release | NeoGenomics Laboratories

August 6, 2018

NeoGenomics Announces Proposed Public Offering of Common Stock

July 24, 2018

NeoGenomics Reports Record Revenue of $67.7 Million with 14% Increase in Clinical Volume Growth and 95% Increase in Pharma Services Backlog

July 2, 2018

NeoGenomics Schedules its Second Quarter Earnings Release for July 24, 2018

June 25, 2018

NeoGenomics Redeems 100% of Series A Redeemable Preferred Stock

June 1, 2018

PPD and NeoGenomics Forming Global Strategic Alliance for Pathology and Molecular Testing Solutions

May 25, 2018

NeoGenomics to Participate In Two Upcoming Investor Conferences

May 1, 2018

NeoGenomics Reports Revenue of $63.4 Million, Net Income of $0.6 Million and Adjusted EBITDA of $9.2 Million in the First Quarter of 2018

April 2, 2018

NeoGenomics Schedules its First Quarter Earnings Release for May 1, 2018

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients